Viatris receives global Minimised Risk of Antimicrobial Resistance certification, ET HealthWorld

[ad_1]

Hyderabad: Viatris Inc. announced today, that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimised Risk of Antimicrobial Resistance (AMR).

The standard was facilitated by BSI for the AMR Industry Alliance, an organization made up of over 100 companies and associations from across the life-sciences industry with the shared goal of providing sustainable solutions to curb AMR. The certification is designed to encourage drug manufacturers and those in the supply chain to prioritise the sustainable production of antibiotics.

“We are proud to be the first pharmaceutical site in India to achieve this important Minimised Risk of Antimicrobial Resistance certification from BSI, demonstrating our commitment to controlling antibiotic discharge,” said Sanjeev Sethi, Chief Operations Officer, Viatris. “Many thanks to our cross-functional team members for continuing to implement sustainable systems and processes that advance the responsible manufacturing of antibiotics.”

“From their initial days with the Alliance, Viatris has been a key contributor to achieving greater results in our shared goal of providing sustainable solutions to curb AMR while being responsible stewards of the environment.” said Steve Brooks, Advisor and Manufacturing Work Group Lead, AMR Industry Alliance.

  • Published On Feb 20, 2024 at 01:01 PM IST

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles


Scan to download App


[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *